Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5933)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2021 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wu J, Xue R, Jiang RT, Meng QH. Characterization of metabolic landscape in hepatocellular carcinoma. World J Gastrointest Oncol 2021; 13(9): 1144-1156 [PMID: PMC8465443 DOI: 10.4251/wjgo.v13.i9.1144] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i9/1144.htm |
| Number | Citing Articles |
| 1 |
Arthur J. L. Cooper, Thambi Dorai, John T. Pinto, Travis T. Denton. Metabolic Heterogeneity, Plasticity, and Adaptation to “Glutamine Addiction” in Cancer Cells: The Role of Glutaminase and the GTωA [Glutamine Transaminase—ω-Amidase (Glutaminase II)] Pathway. Biology 2023; 12(8): 1131 doi: 10.3390/biology12081131
|
| 2 |
Hao Xu, Hui Pan, Lian Fang, Cangyuan Zhang, Chen Xiong, Weiti Cai. A glutamine metabolish-associated prognostic model to predict prognosis and therapeutic responses of hepatocellular carcinoma. Biology Direct 2024; 19(1) doi: 10.1186/s13062-024-00567-x
|
| 3 |
Soo-Mi Kweon, Gayeoun Kim, Yunseong Jeong, Wendong Huang, Ju-Seog Lee, Keane K. Y. Lai. Midnolin Regulates Liver Cancer Cell Growth In Vitro and In Vivo. Cancers 2022; 14(6): 1421 doi: 10.3390/cancers14061421
|
| 4 |
Li Liu, Yi-Ning Li, Aimin Zhang, Yue Yin, Zhihong Yue, Lin Pei, Chang-Sheng Xia, Dong Wang, Mei Jia, Hui Wang, Lin-Lin Cao. Clinical potential of serum prostaglandin A2 as a novel diagnostic biomarker for hepatocellular cancer. Clinica Chimica Acta 2024; 561: 119814 doi: 10.1016/j.cca.2024.119814
|
| 5 |
Xiaopei Peng, Zhenhu He, Dandan Yuan, Zhenguo Liu, Pengfei Rong. Lactic acid: The culprit behind the immunosuppressive microenvironment in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2024; 1879(5): 189164 doi: 10.1016/j.bbcan.2024.189164
|
| 6 |
Joseph C. Ahn. A Global Perspective on Metabolically Driven Primary Liver Cancer: Opportunities and Challenges. American Journal of Gastroenterology 2025; doi: 10.14309/ajg.0000000000003282
|
| 7 |
Monika Komza, Jerry Edward Chipuk. Mitochondrial metabolism: A moving target in hepatocellular carcinoma therapy. Journal of Cellular Physiology 2025; 240(1) doi: 10.1002/jcp.31441
|
| 8 |
Renumathy Dhanasekaran, Hiroyuki Suzuki, Lea Lemaitre, Naoto Kubota, Yujin Hoshida. Molecular and immune landscape of hepatocellular carcinoma to guide therapeutic decision-making. Hepatology 2023; doi: 10.1097/HEP.0000000000000513
|
| 9 |
Amna Hafeez, Zeeshan Khan, Muhammad Armaghan, Khushbukhat Khan, Eda Sönmez Gürer, Ahmad Faizal Abdull Razis, Babagana Modu, Zainab M. Almarhoon, William N. Setzer, Javad Sharifi-Rad. Exploring the therapeutic and anti-tumor properties of morusin: a review of recent advances. Frontiers in Molecular Biosciences 2023; 10 doi: 10.3389/fmolb.2023.1168298
|
| 10 |
Zhongming Bao, Ming Yang, Yunhu Guo, Qi Ge, Huaguo Zhang. MTFR2 accelerates hepatocellular carcinoma mediated by metabolic reprogramming via the Akt signaling pathway. Cellular Signalling 2024; 123: 111366 doi: 10.1016/j.cellsig.2024.111366
|
| 11 |
Anna Gajos-Michniewicz, Malgorzata Czyz. WNT/β-catenin signaling in hepatocellular carcinoma: The aberrant activation, pathogenic roles, and therapeutic opportunities. Genes & Diseases 2024; 11(2): 727 doi: 10.1016/j.gendis.2023.02.050
|
| 12 |
NP Syamprasad, Siddhi Jain, Bishal Rajdev, Neethu Prasad, Ravindra Kallipalli, V.G.M. Naidu. Aldose reductase and cancer metabolism: The master regulator in the limelight. Biochemical Pharmacology 2023; 211: 115528 doi: 10.1016/j.bcp.2023.115528
|